Molecular characterization and biological activity of bovine interferon-omega3

Research in Veterinary Science

Volumn 115, Issue , 2017, Pages 125-131

  An, Dong ^a   Guo, Yongli ^a   Bao, Jun ^a,b   Luo, Xiuxin ^a   Liu, Ying ^a   Ma, Bo ^a   Gao, Mingchun ^a   Wang, Junwei ^a,b  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b National Food Safety and Nutrition Collaborative Innovation Center   (China)

Author keywords

Antiviral activity; Bovine; IFN 3; Interferon stimulated genes; Molecular characteristic

Indexed keywords

ANTIMITOTIC AGENT; ANTIVIRUS AGENT; BOVINE INTERFERON OMEGA 3; GENOMIC DNA; UNCLASSIFIED DRUG; DNA; INTERFERON;

ANIMAL CELL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFECT; EMBRYO; FATTY ACID ANALYSIS; MALE; MAMMAL CELL; MOLECULAR PHYLOGENY; NONHUMAN; PH MEASUREMENT; PHYLOGENETIC TREE; PHYSICAL CHEMISTRY; PROTEIN ANALYSIS; SEQUENCE ALIGNMENT; TEMPERATURE SENSITIVITY; VESICULOVIRUS; ANIMAL; BOVINE; CELL LINE; CHEMISTRY; LIVER; METABOLISM; PHYSIOLOGY; PROTEIN CONFORMATION; VIRUS;

ANIMALS; ANTIVIRAL AGENTS; CATTLE; CELL LINE; DNA; INTERFERON TYPE I; LIVER; PROTEIN CONFORMATION; VIRUSES;

EID: 85013896413     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2017.01.028     Document Type: Article

References (46)

1. Adolf, G.R., Human interferon omega–a review [J]. Mult. Scler. 1:Suppl. 1 (1995), S44–S47.
2. Boue, O., Garcia, J.L., et al. Antiviral and antiluteolytic activity of recombinant bovine IFN-omega1 obtained from Pichia pastoris [J]. J. Interf. Cytokine Res. 20:8 (2000), 677–683.
3. Bracklein, T., Theise, S., Metzler, A., et al. Activity of feline interferon-omega after ocular or oral administration in cats as indicated by Mx protein expression in conjunctival and white blood cells [J]. Am. J. Vet. Res. 67:6 (2006), 1025–1032.
4. Capon, D.J., Shepard, H.M., Goeddel, D.V., Two distinct families of human and bovine interferon-alpha genes are coordinately expressed and encode functional polypeptides [J]. Mol. Cell. Biol. 5:4 (1985), 768–779.
5. Chaplin, P.J., Entrican, G., Gelder, K.I., et al. Cloning and biologic activities of a bovine interferon-alpha isolated from the epithelium of a rotavirus-infected calf [J]. J. Interf. Cytokine Res. 16:1 (1996), 25–30.
6. Charlier, M., L'Haridon, R., Boisnard, M., et al. Cloning and structural analysis of four genes encoding interferon-omega in rabbit. [J]. J. Interf. Res., 13(5), 1993.
7. Charlier, M., L'Haridon, R., Boisnard, M., et al. Cloning and structural analysis of four genes encoding interferon-omega in rabbit [J]. J. Interf. Res. 13:5 (1993), 313–322.
8. Cheng, G., Chen, W., Li, Z., et al. Characterization of the porcine alpha interferon multigene family [J]. Gene 382 (2006), 28–38.
9. Der, S.D., Zhou, A., Williams, B.R., et al. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays [J]. Proc. Natl. Acad. Sci. U. S. A. 95:26 (1998), 15623–15628.
10. Domenech, A., Miro, G., Collado, V.M., et al. Use of recombinant interferon omega in feline retrovirosis: from theory to practice [J]. Vet. Immunol. Immunopathol. 143:3–4SI (2011), 301–306.
11. Gil, S., Leal, R.O., Mcgahie, D., et al. Oral recombinant feline interferon-omega as an alternative immune modulation therapy in FIV positive cats: clinical and laboratory evaluation [J]. Res. Vet. Sci. 96:1 (2014), 79–85.
12. Guo, Y., Gao, M., Bao, J., et al. Molecular cloning and characterization of a novel bovine IFN-epsilon [J]. Gene 558:1 (2015), 25–30.
13. Hagelstein, J., Kist, A., Stremmel, W., et al. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells [J]. Arzneimittelforschung 48:3 (1998), 343–347.
14. Hauptmann, R., Swetly, P., A novel class of human type I interferons [J]. Nucleic Acids Res. 13:13 (1985), 4739–4749.
15. Himmler, A., Hauptmann, R., Adolf, G.R., et al. Molecular cloning and expression in Escherichia coli of equine type I interferons [J]. DNA 5:5 (1986), 345–356.
16. Horton, H.M., Hernandez, P., Parker, S.E., et al. Antitumor effects of interferon-omega: in vivo therapy of human tumor xenografts in nude mice.[J]. Cancer Res., 59(16), 1999.
17. Krause, C.D., Pestka, S., Evolution of the Class 2 cytokines and receptors, and discovery of new friends and relatives [J]. Pharmacol. Ther. 106:3 (2005), 299–346.
18. Leal, R.O., Gil, S., Sepulveda, N., et al. Monitoring acute phase proteins in retrovirus infected cats undergoing feline interferon-omega therapy [J]. J. Small Anim. Pract. 55:1 (2014), 39–45.
19. Lehner, T., Wang, Y., Pido-Lopez, J., et al. The emerging role of innate immunity in protection against HIV-1 infection [J]. Vaccine 26:24 (2008), 2997–3001.
20. Litzlbauer, P., Weber, K., Mueller, R.S., Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega [J]. Cytokine 66:1 (2014), 54–59.
21. − ΔΔCT method. Methods, 25(4), 2001, 402e8.
22. Luo, X., Guo, Y., Bao, J., et al. Characterization and antivirus activities of a novel bovine IFN-omega24 [J]. Mol. Immunol. 66:2 (2015), 357–363.
23. Martin, V., Najbar, W., Gueguen, S., et al. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial [J]. Vet. Microbiol., 89(2–3), 2002.
24. Mege, D., Lefevre, F., Labonnardiere, C., The porcine family of interferon-omega: cloning, structural analysis, and functional studies of five related genes [J]. J. Interf. Res., 11(6), 1991.
25. Mochizuki, M., Nakatani, H., Yoshida, M., Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro [J]. Vet. Microbiol. 39:1–2 (1994), 145–152.
26. Ohe, K., Takahashi, T., Hara, D., et al. Sensitivity of FCV to recombinant feline interferon (rFeIFN) [J]. Vet. Res. Commun. 32:2 (2008), 167–174.
27. Roberts, R.M., Liu, L., Guo, Q., et al. The evolution of the type I interferons [J]. J. Interf. Cytokine Res. 18:10 (1998), 805–816.
28. Rodriguez, M., Martinez, V., Alazo, K., et al. The bovine IFN-omega 1 is biologically active and secreted at high levels in the yeast Pichia pastoris [J]. J. Biotechnol. 60:1–2 (1998), 3–14.
29. Rodriguez, M., Martinez, V., Alazo, K., et al. The bovine IFN-omega 1 is biologically active and secreted at high levels in the yeast Pichia pastoris [J]. J. Biotechnol. 60:1–2 (1998), 3–14.
30. Rubinstein, S., Familletti, P.C., Pestka, S., Convenient assay for interferons [J]. J. Virol. 37:2 (1981), 755–758.
31. Ryan, A.M., Womack, J.E., Type I interferon genes in cattle: restriction fragment length polymorphisms, gene numbers and physical organization on bovine chromosome 8 [J]. Anim. Genet. 24:1 (1993), 9–16.
32. Sambrook, J., Green, M.R., Molecular Cloning: a Laboratory Manual [Z]. 2012, Cold Spring Harbor Laboratory Press.
33. Schneider, W.M., Chevillotte, M.D., Rice, C.M., Interferon-stimulated genes: a complex web of host defenses [J]. Annu. Rev. Immunol. 32 (2014), 513–545.
34. Schoggins, J.W., Interferon-stimulated genes: roles in viral pathogenesis [J]. Curr. Opin. Virol. 6 (2014), 40–46.
35. Sen, G.C., Viruses and interferons [J]. Annu. Rev. Microbiol. 55 (2001), 255–281.
36. Shao, J., Cao, C., Bao, J., et al. Characterization of the biological activities and physicochemical characteristics of recombinant bovine interferon-alpha 14 [J]. Mol. Immunol. 64:1 (2015), 163–169.
37. Shao, J., Cao, C., Bao, J., et al. Characterization of bovine interferon alpha1: expression in yeast Pichia pastoris, biological activities, and physicochemical characteristics [J]. J. Interf. Cytokine Res. 35:3 (2015), 168–175.
38. Staeheli, P., Interferon-induced proteins and the antiviral state [J]. Adv. Virus Res. 38 (1990), 147–200.
39. Stark, G.R., Kerr, I.M., Williams, B.R., et al. How cells respond to interferons [J]. Annu. Rev. Biochem. 67 (1998), 227–264.
40. Terenzi, F., Hui, D.J., Merrick, W.C., et al. Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56 [J]. J. Biol. Chem. 281:45 (2006), 34064–34071.
41. Tiefenthaler, M., Geisen, F., Schirmer, M., et al. A comparison of the antiproliferative properties of recombinant human IFN-alpha 2 and IFN-omega in human bone marrow culture [J]. J. Interf. Cytokine Res. 17:6 (1997), 327–329.
42. Velan, B., Cohen, S., Grosfeld, H., et al. Bovine interferon alpha genes. Structure and expression [J]. J. Biol. Chem. 260:9 (1985), 5498–5504.
43. Wacher, C., Muller, M., Hofer, M.J., et al. Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses [J]. J. Virol. 81:2 (2007), 860–871.
44. Wetzel, R., Assignment of the disulphide bonds of leukocyte interferon [J]. Nature 289:5798 (1981), 606–607.
45. Yang, L.M., Xue, Q.H., Sun, L., et al. Cloning and characterization of a novel feline IFN-omega [J]. J. Interf. Cytokine Res. 27:2 (2007), 119–127.
46. Zhao, X., Cheng, G., Yan, W., et al. Characterization and virus-induced expression profiles of the porcine interferon-omega multigene family [J]. J. Interf. Cytokine Res. 29:10 (2009), 687–693.